FALLS CHURCH, Va., May 15, 2019 /PRNewswire-PRWeb/ -- Four Hot Topics in FDA Regulation & Compliance: Opioids, Biosimilars,
From opioids to biosimilars, from right-to-try to dietary supplements, controversies continue as the agency, Congress and the White House feel their way toward a new approach to life science regulation.
The fight takes place outside Washington too, with dozens of measures in state legislature hoppers.
Join noted FDA legal expert Roseann B. Termini Esq. for the real skinny on four top issues. Attendees will discover everything one needs to know in just 90 minutes including:
From drugs to biotech, devices to diagnostics, every FDA-regulated player could do with a crystal ball. We offer the closest thing.
Interested in registering multiple sites? Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.
Webinar Details: Four Hot Topics in FDA Regulation & Compliance: Opioids, Biosimilars, Right-to-Try and Dietary Supplements **An FDAnews Webinar** Wednesday, May 29, 2019, 1:30-3:00p.m. EDT https://www.fdanews.com/fourhottopics
Tuition: $287 per site
Easy Ways to Register: Online: https://www.fdanews.com/fourhottopics By phone: 888-838-5578 or 703-538-7600
About FDAnews: FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
Subscribe to our Free Newsletters!